Sign in
HROWL Stock Price, Chart, Stats & News
Harrow Health, Inc. 8.625% Senior Notes due 2026
Save
1.37B
Market cap
–
Current P/E
–
Forward P/E
HROWL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.05% |
Operating margin | 11.21% |
Pretax margin | -3.27% |
Net margin | -1.89% |
Effective tax rate | 42.32% |
ROA | -1.29% |
ROE | -10.00% |
D/E | 4.80x |
Interest coverage ratio | 1.26x |
HROWL valuation
P/E | – |
P/S | 4.63x |
P/B | 23.71x |
P/CF | 28.35x |
P/FCF | 29.33x |
P/OCF | 28.35x |
PEG | 33.88x |
EV multiple | 28.37x |
About
Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business.
Similar securities
Based on sector and market capitalization
Report issue